Stem Cell Manufacturing Market Size, Share, Growth Analysis, By Product(Consumables (Culture Media, Other Consumables), Instruments (Bioreactors & Incubators, Cell Sorters), By Application (Research Applications (Life Science Research, Drug Discovery & Development), Clinical Applications (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy)), By End User(Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories, and Contract Research Organizations), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35B2172 | Region: Global | Published Date: October, 2024
Pages: 157 |Tables: 61 |Figures: 75

Stem Cell Manufacturing Market Insights

Stem Cell Manufacturing Market size was valued at USD 12.58 Billion in 2022 and is poised to grow from USD 13.76 Billion in 2023 to USD 28.23 Billion by 2031, at a CAGR of 9.4% during the forecast period (2024-2031).

The stem cell manufacturing market growth is driven by the technological innovations in the manufacture and storage of stem cells, along with growing public awareness about the medicinal properties of products related to stem cells. According to a paper in PubMed dated September 2022, the treatment of many diseases by stem cells, based on in vitro and in vivo studies, is considered safe and effective. This treatment is believed to be based on human stem cells, such as iPSCs, ASCs, and ESCs, that are supposed to help in repairing or reconstructing damaged organs and congenital deformities. Many more public and private organizations will combine to address common issues connected with the production and processing of stem cell banks, enhancing operation and driving the growth of the market. For instance, in the last quarter of 2021, STEMCELL Technologies launched human pluripotent stem cell characterization and banking services in collaboration with WiCell. The services, provided by STEMCELL's Contract Assay Services department, allow researchers to make cell banks through standardized procedures and then receive detailed assessments of their cell quality. Hence, during the forecast period, the studied segment is expected to witness significant growth as studies related to the research of stem cell treatment rise, and with that, programs and funding towards the establishment of stem cell banks also witness an increase.

US Stem Cell Manufacturing Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot - 2024-2031

Global Market Size

USD 11.5 Billion

Largest Segment

Direct sales

Fastest Growth

Direct Sales

Growth Rate

9.4% CAGR

Global Stem Cell Manufacturing Market ($ Bn)
Country Share for North America Region (%)

To get more reports on the above market click here to Buy The Report

Stem Cell Manufacturing Market Segmental Analysis

Global Stem Cell Manufacturing Market is segmented by Product, Application, End User and Region. Based on Product, the market is segmented into Consumables (Culture Media, Other Consumables), Instruments (Bioreactors & Incubators, Cell Sorters, Other Instruments), Stem Cell Lines (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Neural Stem Cells, Multipotent Adult Progenitor Stem Cells). Based on Application, the market is segmented into Research Applications (Life Science Research, Drug Discovery & Development), Clinical Applications (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell & Tissue Banking Applications. Based on End User, the market is segmented into Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories, and Contract Research Organizations, Hospitals & Surgical Centers, Cell & Tissue Banks, Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Stem Cell Manufacturing Market Analysis by Product 

The consumables segment held the largest stem cell manufacturing market share, accounting for a considerable share of total revenue. Consumables are essential for the development, maintenance, and differentiation of stem cells, which explains their dominance. Culture medium, reagents, growth factors, and kits are important goods in this category as they are essential for the effective study of stem cells and their medicinal uses. With the growth in demand for stem cell-based treatments, there has been a rising need for premium consumables. Consecutive consumption of these inevitable materials is also being influenced by continuous improvement in technologies related to stem cells and an increase in clinical trials that have further anchored their vital position in the market. 

However, as per the stem cell manufacturing market analysis, the instruments segment has experienced rapid technical advancement and an increasing demand for high technology equipment, making it the fastest growth rate. Innovated automation of cell cultures, high technology imaging facilities, and cell sorting equipment makes stem cell investigation and production more accurate and efficient. The demand for these apparatuses is rising with further investment in clinical labs and research institutes regarding advanced apparatuses. This upward trend is also influenced due to the increased applications in drug development, personalized therapies, and regenerative medicines of stem cells. As the production and research of this cell type undergo changes over the next few years, this market will increase noticeably. 

Stem Cell Manufacturing Market Analysis by Application 

The market leader for the stem cell manufacturing industry is the research applications segment. This segment is dominant due to an extensive use of stem cells for pharmaceutical and academic research related to the investigation of diseases caused, basic biological processes and possible treatment approaches. Researchers use stem cells to study gene expression, cellular differentiation, or even the creation of a novel approach for disease treatments. Excellent quality stem cell lines and accessories continue to be in big demand due to the steady growth in the understanding of stem cell biology. Based on this, research applications will be the key area of the market expansion as a lifeline for the production of stem cells. 

The clinical applications field is where the stem cell manufacturing industry is evolving at the fastest rate in terms of growth. Due to increased acceptance of treatments derived from stem cells, rapid research developments in regenerative medicine, and advancements into clinic practice, researchers are conducting research into stem cells about a range of conditions involving neurological injuries, cardiovascular diseases, and autoimmune diseases. The increased clinical research and regulatory clearances for drugs using stem cells will further drive this growth. Moreover, growing awareness in the medical field about customized medicine is increasing the requirement for efficient therapies using stem cells. Such rapid growth marks out the bright prospect of therapeutic applications in the production of stem cells.

Global Stem Cell Manufacturing Market By Distribution Channel

To get detailed analysis on other segments, Request For Free Sample Report

Stem Cell Manufacturing Market Regional Insights

As per the stem cell manufacturing market forecast, North America dominated the industry. Among such drivers of growth are the intensive stem cell research, significant public-private funding and grant for the clinical evaluation of stem cells for various purposes, a robust research infrastructure, and growing public appreciation of the therapeutic potential of stem cells. For instance, in April 2022, the Stem Cell Network (SCN) of Canada revealed IGNITE 2022-2025, which is the three-year strategic plan funded by the Government of Canada under its commitment from Budget 2021 for USD 45 million. Training, knowledge mobilization, and research can be announced to be the three main pillars of IGNITE 2022-2025. As SCN is set out to put scientists and the knowledge that emanates from Canada at the helm of world regenerative medicine (RM), each is very core to it.  

Asia-Pacific is emerging as the fastest growing region in the stem cell manufacturing industry. There are various reasons for the rapid growth of stem cell production in Asia Pacific. This region has begun to experience high government support to enhance stem cell research and developments, massive investment in health care infrastructure, and also collaboration in research among others. Breakthroughs in the region include China, Japan, and South Korea. The Asia Pacific stem cell production market is expanding because of an increasingly large patient base, increasing awareness of regenerative medicine, and increasing healthcare costs.

Global Stem Cell Manufacturing Market By Region
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Stem Cell Manufacturing Market Dynamics

Stem Cell Manufacturing Market Drivers

Advances in Regenerative Medicine 

  • The rising interest in regenerative medicine significantly drives demand for stem cell production. New technologies and methods allow the possible applications of stem cells to increase, for instance, from generating bespoke treatments to managing chronic diseases. This advances the demand for stem cell goods and services in both clinical and research settings and further promotes more funding for the research and development of stem cells. 

Increasing Incidence of Chronic Diseases 

  • The increasing cases of chronic conditions such as diabetes, heart problems, and neurological diseases call for the need to use stem cell therapy treatment. Healthcare organizations are constantly looking for means of handling these challenging diseases, thus increasing the demand for therapies based on the use of stem cells. This factor is therefore forcing more investments in the application of clinical use for the technology based on stem cells. 

Restraints  

Regulatory Obstacles Regarding Stem Cell Applications 

  • There are a lot of barriers that the stem cell manufacturing industry has to face before getting into the challenging and complicated regulatory field. With stiff regulations regarding the application of stem cells in lab experiments and clinical trials, it will tend to elongate product development and approval cycles. Firms cannot avoid these shackles but seek ingenuity within them; hence they will lessen investment and limit expansion of the market. 

Ethical Issues of Embryonic Stem Cells 

  • Ethical issues surrounding the application of embryonic stem cells continue to heavily limit the market. Funding for research related to the same may be withheld and regulatory limits may be imposed owing to public anxieties regarding the ethical implications of stem cell research. Such ethical dilemmas would further limit the application of some stem cell treatments within the medical fraternity and in society and also impede their discovery.

Request Free Customization of this report to help us to meet your business objectives.

Stem Cell Manufacturing Market Competitive Landscape

The highly competitive global stem cell manufacturing industry includes many companies that compete for market share and a competitive advantage. This market comprises research institutes, biotechnology companies, and international pharmaceutical firms. To strengthen their capability to manufacture stem cells and increase their products, these companies are constantly conducting research and development. The leading companies in the industry are working on innovative manufacturing technologies, improving cell culture techniques, and making stem cell production reproducible and scalable. It is believed that these efforts will be able to capitalize on market opportunities and meet the demand for cell-based therapies.

Stem Cell Manufacturing Market Top Player’s Company Profile

  • Thermo Fisher Scientific, Inc. 
  • Merck KGaA 
  • Lonza Group Ltd. 
  • Danaher Corporation 
  • Sartorius AG 
  • Becton, Dickinson and Company 
  • Eppendorf SE 
  • Corning Incorporated 
  • Bio-Rad Laboratories, Inc. 
  • Takara Bio Inc. 
  • Fujifilm Holdings Corporation 
  • Getinge AB 
  • Terumo Corporation 
  • Bio-Techne Corporation 
  • Himedia Laboratories Pvt. Ltd. 
  • Stemcell Technologies, Inc. 
  • Miltenyi Biotec GmbH 
  • Promocell 
  • Anterogen Co. Ltd. 
  • Cellgenix GmbH 
  • Pluristem Therapeutics Inc. 
  • Daiichi Sankyo 
  • Organogenesis Holdings Inc. 
  • Vericel Corp. 
  • American Cryostem Corp.

Stem Cell Manufacturing Market Recent Developments

  • In March 2023, it was announced by the MHRA that automated robotic technology for stem cell growth is undergoing trials at its UK Stem Cell Bank. 
  • In August 2022, the good manufacturing facility of Applied StemCell, Inc. (ASC) was expanded. Moreover, the Current Good Manufacturing facility of Applied StemCell, Inc. (ASC), a leading CRO/CDMO exclusively focusing on fulfilling the demands of the biotech sector and research community toward developing and manufacturing cell and gene products, with four additional cGMP cleanrooms and cryo-storage space, along with Process development and QC /QA areas. 
  • In January 2022, Cellino Biotech, a firm which specializes in manufacturing stem cells, raised USD 80 million in Series A funding, led by Leaps by Bayer and co-invested by 8VC, Humboldt Fund, and new investors Felicis Ventures and Khosla Ventures. This will help overcome the hindrance to the biotech industry and build the first-ever autonomous human cell foundry by 2025, along with making stem cell-based treatments accessible.

Stem Cell Manufacturing Key Market Trends

  • Combining Cutting-Edge Technologies: One of the key stem cell manufacturing trends includes combination of advanced technologies. With 3D bioprinting and CRISPR gene editing on the rise as the most recent technological advances, this field is moving in strides. Thus, more streamlined and accurate manufacturing of stem cells along with more significant research are to be conducted within this domain, leading to much more productive therapy and subsequent interest and funding. 
  • Increased Focus on Individualized Drugs: A new trend in the industry is moving toward customized treatment. In this regard, stem cells are increasingly being used for the development of drugs tailored to the needs of individual patients as healthcare is moving toward customized treatment strategies. The change is creating more collaboration between scientists, physicians, and industry players, leading to the development of customized treatments that utilize each patient's unique genetic and biological profiles.

Stem Cell Manufacturing Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research. 

As per SkyQuest analysis, the stem cell manufacturing market outlook is predicted to change highly because of advances in regenerative medicine, the increasing prevalence of chronic diseases, and the increasing need for tailored treatments. The need for better products and technology of stem cells will rise with more research that points up the tremendous potential of this product both in academic as well as clinical settings. However, this market has to face the problems of ethical dilemmas and complicated regulations to realize their full potential. The future appears bright for the industry, as further developments and partnership among major companies can help bring revolutionary improvements in the outcomes of patients and health care.

Report Metric Details
Market size value in 2022 USD 12.58 Billion
Market size value in 2031 USD 28.23 Billion
Growth Rate 9.4%
Base year 2023
Forecast period 2024-2031
Forecast Unit (Value) USD Billion
Segments covered
  • Product
    • Consumables (Culture Media, Other Consumables), Instruments (Bioreactors & Incubators, Cell Sorters, Other Instruments), Stem Cell Lines (Hematopoietic Stem Cells, Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells, Neural Stem Cells, Multipotent Adult Progenitor Stem Cells)
  • Application 
    • Research Applications (Life Science Research, Drug Discovery & Development), Clinical Applications (Allogeneic Stem Cell Therapy, Autologous Stem Cell Therapy), Cell & Tissue Banking Applications
  • End User
    • Pharmaceutical & Biotechnology Companies, Academic Institutes, Research Laboratories, and Contract Research Organizations, Hospitals & Surgical Centers, Cell & Tissue Banks, Other End Users
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Thermo Fisher Scientific, Inc. 
  • Merck KGaA 
  • Lonza Group Ltd. 
  • Danaher Corporation 
  • Sartorius AG 
  • Becton, Dickinson and Company 
  • Eppendorf SE 
  • Corning Incorporated 
  • Bio-Rad Laboratories, Inc. 
  • Takara Bio Inc. 
  • Fujifilm Holdings Corporation 
  • Getinge AB 
  • Terumo Corporation 
  • Bio-Techne Corporation 
  • Himedia Laboratories Pvt. Ltd. 
  • Stemcell Technologies, Inc. 
  • Miltenyi Biotec GmbH 
  • Promocell 
  • Anterogen Co. Ltd. 
  • Cellgenix GmbH 
  • Pluristem Therapeutics Inc. 
  • Daiichi Sankyo 
  • Organogenesis Holdings Inc. 
  • Vericel Corp. 
  • American Cryostem Corp.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Stem Cell Manufacturing Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Stem Cell Manufacturing Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Stem Cell Manufacturing Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Stem Cell Manufacturing Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Stem Cell Manufacturing Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Stem Cell Manufacturing Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Stem Cell Manufacturing Market size was valued at USD 12.58 Billion in 2022 and is poised to grow from USD 13.76 Billion in 2023 to USD 28.23 Billion by 2031, at a CAGR of 9.4% during the forecast period (2024-2031).

The highly competitive global stem cell manufacturing industry includes many companies that compete for market share and a competitive advantage. This market comprises research institutes, biotechnology companies, and international pharmaceutical firms. To strengthen their capability to manufacture stem cells and increase their products, these companies are constantly conducting research and development. The leading companies in the industry are working on innovative manufacturing technologies, improving cell culture techniques, and making stem cell production reproducible and scalable. It is believed that these efforts will be able to capitalize on market opportunities and meet the demand for cell-based therapies. 'Thermo Fisher Scientific, Inc. ', 'Merck KGaA ', 'Lonza Group Ltd. ', 'Danaher Corporation ', 'Sartorius AG ', 'Becton, Dickinson and Company ', 'Eppendorf SE ', 'Corning Incorporated ', 'Bio-Rad Laboratories, Inc. ', 'Takara Bio Inc. ', 'Fujifilm Holdings Corporation ', 'Getinge AB ', 'Terumo Corporation ', 'Bio-Techne Corporation ', 'Himedia Laboratories Pvt. Ltd. ', 'Stemcell Technologies, Inc. ', 'Miltenyi Biotec GmbH ', 'Promocell ', 'Anterogen Co. Ltd. ', 'Cellgenix GmbH ', 'Pluristem Therapeutics Inc. ', 'Daiichi Sankyo ', 'Organogenesis Holdings Inc. ', 'Vericel Corp. ', 'American Cryostem Corp.'

The rising interest in regenerative medicine significantly drives demand for stem cell production. New technologies and methods allow the possible applications of stem cells to increase, for instance, from generating bespoke treatments to managing chronic diseases. This advances the demand for stem cell goods and services in both clinical and research settings and further promotes more funding for the research and development of stem cells. 

Combining Cutting-Edge Technologies: One of the key stem cell manufacturing trends includes combination of advanced technologies. With 3D bioprinting and CRISPR gene editing on the rise as the most recent technological advances, this field is moving in strides. Thus, more streamlined and accurate manufacturing of stem cells along with more significant research are to be conducted within this domain, leading to much more productive therapy and subsequent interest and funding. 

As per the stem cell manufacturing market forecast, North America dominated the industry. Among such drivers of growth are the intensive stem cell research, significant public-private funding and grant for the clinical evaluation of stem cells for various purposes, a robust research infrastructure, and growing public appreciation of the therapeutic potential of stem cells. For instance, in April 2022, the Stem Cell Network (SCN) of Canada revealed IGNITE 2022-2025, which is the three-year strategic plan funded by the Government of Canada under its commitment from Budget 2021 for USD 45 million. Training, knowledge mobilization, and research can be announced to be the three main pillars of IGNITE 2022-2025. As SCN is set out to put scientists and the knowledge that emanates from Canada at the helm of world regenerative medicine (RM), each is very core to it.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Stem Cell Manufacturing Market

Report ID: SQMIG35B2172

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE